AstraZeneca updated its data late Wednesday on the effectiveness of its coronavirus vaccine candidate amid U.S. concern about misleading data, but maintained that the vaccine provides strong protection against the potentially deadly virus.
AstraZeneca updated its data late Wednesday on the effectiveness of its coronavirus vaccine candidate amid U.S. concern about misleading data, but maintained that the vaccine provides strong protection against the potentially deadly virus.